CCMH
PCRX icon

Cornerstone Capital Management Holdings’s Pacira BioSciences PCRX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$533K Sell
11,700
-48,700
-81% -$1.93M ﹤0.01% 1002
2017
Q3 		$2.27M Buy
+60,400
New +$2.43M 0.02% 696
2016
Q4 		– Sell
-52,300
Closed -$1.79M – 1400
2016
Q3 		$1.79M Buy
+52,300
New +$2.05M 0.01% 797

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Cornerstone Capital Management Holdings's PCRX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Pacira BioSciences (PCRX) stake by 81% in Q4 2017, selling an estimated $1.93M and leaving 11,700 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

Cornerstone Capital Management Holdings first reported a position in PCRX in Q3 2016 and has held it in 3 quarters since. The position peaked at $2.27M in Q3 2017. 185 funds tracked by Wall St. Rank hold PCRX as of Q4 2017.

  • Cornerstone Capital Management Holdings held 11,700 shares of Pacira BioSciences worth $533K as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 48,700 Pacira BioSciences shares in Q4 2017, an estimated $1.93M.
  • Pacira BioSciences made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #1002 holding.
  • Cornerstone Capital Management Holdings first reported a position in Pacira BioSciences in Q3 2016 and has held it in 3 quarters since.
  • Cornerstone Capital Management Holdings's Pacira BioSciences position peaked at $2.27M in Q3 2017.
  • 185 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.